Discussion on: Adjuvant systemic therapy for intermediate and large gastric gastrointestinal stromal tumors (GISTs): Is there a survival benefit following margin negative surgical resection? - 18/03/20
Doi : 10.1016/j.amjsurg.2019.10.044
D. Patel ⁎, W.Lutfi P. Sweigert, E. Eguia, G. Abood, L. Knab, P.C. Kuo, M.S. Baker
∗Corresponding author.
© 2019
Publicado por Elsevier Masson SAS.
Vol 219 - N° 3
P. 440-441 - mars 2020 Regresar al número
Artículo precedente
- Adjuvant systemic therapy for intermediate and large gastric gastrointestinal stromal tumors (GISTs): Is there a survival benefit following margin negative surgical resection?
- Dhruv J. Patel, Waseem Lutfi, Patrick Sweigert, Emanuel Eguia, Gerard Abood, Lawrence Knab, Paul C. Kuo, Marshall S. Baker
- What predicts successful nonoperative management with botulinum toxin for anal fissure?
- Roxanne Kyriakakis, Kathrine Kelly-Schuette, Rebecca Hoedema, Martin Luchtefeld, James Ogilvie
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?